Peptide profiling of cerebrospinal fluid by mass spectrometry

被引:12
作者
Dekker, Lennard J.
Burgers, Peter C.
Kros, Johan M.
Smitt, Peter A. E. Sillevis
Luider, Theo M.
机构
[1] Erasmus Univ, Med Ctr, Dept Neurol, Lab Neurooncol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
关键词
biomarker; proteomics; MALDI-FT ion cyclotron resonance; MALDI-TOF; mass spectrometry; peptide profiling;
D O I
10.1586/14789450.3.3.297
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The search for biomarkers is driven by the increasing clinical importance of early diagnosis. Reliable biomarkers can also assist in directing therapy, monitoring disease activity and the efficacy of treatment. In addition, the discovery of novel biomarkers might provide clues to the pathogenesis of a disease. The dynamic range of protein concentrations in body fluids exceeds 10 orders of magnitude. These huge differences in concentrations complicate the detection of proteins with low expression levels. Since all classical biomarkers have low expression levels (e.g., prostate-specific antigen: 2-4 mu g/l; and CA125: 20-35 U/ml), new developments with respect to identification and validation techniques of the low-abundance proteins are required. This review will discuss the current status of profiling cerebrospinal fluid using mass spectrometry-based techniques, and new developments in this area.
引用
收藏
页码:297 / 309
页数:13
相关论文
共 86 条
[11]   Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry [J].
Bons, JAP ;
de Boer, D ;
van Dieijen-Visser, MP ;
Wodzig, WKWH .
CLINICA CHIMICA ACTA, 2006, 366 (1-2) :249-256
[12]  
Börnsen KO, 2000, METH MOL B, V146, P387, DOI 10.1385/1-59259-045-4:387
[13]   A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease [J].
Carrette, O ;
Demalte, I ;
Scherl, A ;
Yalkinoglu, O ;
Corthals, G ;
Burkhard, P ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2003, 3 (08) :1486-1494
[14]   Utility of accurate mass tags for proteome-wide protein identification [J].
Conrads, TP ;
Anderson, GA ;
Veenstra, TD ;
Pasa-Tolic, L ;
Smith, RD .
ANALYTICAL CHEMISTRY, 2000, 72 (14) :3349-3354
[15]   Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice [J].
de Boer, E ;
Rodriguez, P ;
Bonte, E ;
Krijgsveld, J ;
Katsantoni, E ;
Heck, A ;
Grosveld, F ;
Strouboulis, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7480-7485
[16]  
DEKKER L, 2006, IDENTIFICATION SIGNI
[17]   MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer [J].
Dekker, LJ ;
Boogerd, W ;
Stockhammer, G ;
Dalebout, JC ;
Siccama, I ;
Zheng, PP ;
Bonfrer, JM ;
Verschuuren, JJ ;
Jenster, G ;
Verbeek, MM ;
Luider, TM ;
Smitt, PAS .
MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (09) :1341-1349
[18]   A new method to analyze matrix-assisted laser desorption/ionization time-of-flight peptide profiling mass spectra [J].
Dekker, LJ ;
Dalebout, JC ;
Siccama, I ;
Jenster, G ;
Smitt, PAS ;
Luider, TM .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (07) :865-870
[19]   Analysis of serum proteomic patterns for early cancer diagnosis: Drawing attention to potential problems [J].
Diamandis, EP .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05) :353-356
[20]  
Diamandis EP, 2005, CLIN CANCER RES, V11, P963